Doximity Reports Fiscal Q1 2025 Financial Results
Intellectia.AI1970-01-01
Doximity Reports Fiscal Q1 2025 Financial Results
Doximity, Inc. (NYSE:DOCS), the foremost digital platform for U.S. medical professionals, announced its fiscal 2025 first-quarter financial results for the period ending June 30, 2024.
Key Financial Metrics
| Metric | Q1 2025 (Jun 30, 2024) | Q4 2024 | YoY Growth | Consensus Estimate | Comparison to Estimate |
|---|---|---|---|---|---|
| Total Revenue | $126.7 million | $108.5M | 17% | $119.92 million | Above by $6.78 million |
| Net Income | $41.4 million | $28.4M | 46% | Not provided | - |
| Adjusted EBITDA | $65.9 million | $46.6M | 42% | Not provided | - |
| Diluted Net Income per Share | $0.21 | $0.13 | 61.5% | $0.22 | Below by $0.01 |
| Non-GAAP Diluted Net Income per Share | $0.28 | $0.19 | 47.4% | Not provided | - |
Doximity has demonstrated robust financial performance in fiscal Q1 2025, surpassing revenue expectations and exhibiting strong year-over-year growth in both net income and adjusted EBITDA. Though slightly missing the consensus EPS estimate by $0.01, the company still saw a significant increase in profitability.
Revenue Performance Across Major Segments
| Segment | Q1 2025 Revenue | Previous Guidance | Comparison to Guidance |
|---|---|---|---|
| Total | $126.7 million | $119.92 million | Above by $6.78 million |
The company's revenues outpaced its previous guidance, indicating strong market performance and demand for its digital tools for medical professionals.
Comments from Company Officers
Jeff Tangney, co-founder and CEO of Doximity, highlighted the company's exceptional engagement and profitability, stating, "Last quarter, a record 590,000 unique providers used our AI, telehealth, messaging, and scheduling workflow tools to save time and better serve their patients."
Dividends or Share Repurchase Program
The earnings release did not mention any announcements regarding dividends or a share repurchase program.
Forward Guidance
For the fiscal second quarter ending September 30, 2024, Doximity provided the following guidance: - Revenue: Between $126.5 million and $127.5 million. - Adjusted EBITDA: Between $62.5 million and $63.5 million.
For the fiscal year ending March 31, 2025, the Company provided: - Revenue: Between $514 million and $523 million. - Adjusted EBITDA: Between $248.5 million and $257.5 million.
Stock Price Movement
Post-earnings release, Doximity's stock price experienced a significant increase, with an after-event change of 19.1%.
This concise summary encompasses the financial performance, key metrics, segmental revenue, and forward-looking guidance based on Doximity Inc.'s fiscal Q1 2025 earnings report.
Tesla's Robotaxi Launch Sparks New Market Momentum: What Investors Need to Know
Great News for Lucid Investors: Is Now the Time to Buy Lucid Stock?
Exploring IonQ Stock: Is This Quantum Computing Pioneer a Smart Investment?
Share